Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 09, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%.".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 09, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Bromfenac Ophthalmic Solution, 0.07%.".